<DOC>
	<DOCNO>NCT02539069</DOCNO>
	<brief_summary>A clinical trial evaluate long-term efficacy safety Chondron ( Autologous culture Chondrocyte ) administer arthroscopy drug 's 48 week efficacy safety evaluation 96 week follow-up patient knee cartilage defect .</brief_summary>
	<brief_title>The Post-marketing Surveillance Evaluate Efficacy CHONDRON ( Autologous Cultured Chondrocyte ) Arthroscopy</brief_title>
	<detailed_description>This open trial , involve total 10 subject . Subjects give consent screen meet trial criterion receive CHONDRON ( Autologous culture Chondrocyte ) transplant . During trial period , subject must follow instruction give principal investigator . Subjects make 8* hospital visit regular basis inclusive hospitalization . During visit subject examine . For evaluation safety efficacy CHONDRON , examination doctor , blood sample , x-ray , MRI test , observation naked eye arthroscopy perform . *If tissue sample collect screen visit , 7 visit .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<criteria>1 . Patients cartilage defect knee ( Including Knee OA Knee TA ) * For single lesion , less 15 cm2 cartilage defect ; multiple lesion , less 20 cm2 2 . Patients misalignment tibia femur , unstable ligament knee , bony defect lesion knee , and/or treat alignment 3 . Patients surround cartilage normal 4 . Patients 15 year old old 5 . Patients representative ( adult ) , patient parent/guardian ( minor ) , agree participate study sign informed consent form 1 . Patients hypersensitive bovine protein 2 . Patients hypersensitive gentamicin antibiotic 3 . Patients inflammatory arthritis rheumatoid arthritis , gout arthritis 4 . Patients arthritis relate autoimmune disease 5 . Pregnant , breastfeed patient possibility pregnancy 6 . Patients accompany disease articular cartilage defect , include tumor ( Exception : possibility Chondron treatment confirm doctor 's clinical decision ) . 7 . Patients history receive radiotherapy , chemotherapy last 2 year ( Exception : possibility Chondron treatment confirm doctor 's clinical decision ) . 8 . Patients diabetes ( however , patient whose blood sugar test result normal complication diabetes , write opinion CHONDRON administration possible append doctor exclude ) 9 . Patients infection require hospitalization antibiotic administration antiseptic agent 10 . Patients adrenocorticoid therapy ( Exception : possibility Chondron treatment confirm doctor 's clinical decision ) . 11 . Patients psychiatric disorder consider inappropriate trial judgment clinical trial manager 12 . Patients cartilage defect knee ( If necessity surgery opposite side knee joint use Chondron confirm doctor 's clinical decision ) . 13 . Patients liver , heart , kidney disease ( Those show normal insignificant test result may enrol study receive Chondron base investigator 's judgment . Hypertension patient allow . ) 14 . Patients infected virus ( Those show normal insignificant test result may enrol study receive Chondron base investigator 's judgment . ) 15 . Patients participate another clinical trial ( limited participate study fracture within last six month . )</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>cartilage defect</keyword>
	<keyword>Chondron</keyword>
	<keyword>Autologous culture Chondrocyte</keyword>
	<keyword>arthroscopy</keyword>
</DOC>